Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2004
10/20/2004EP1194450B1 Inactivated vaccine against feline calicivirus disease
10/20/2004EP1181381B1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
10/20/2004EP1154790B1 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
10/20/2004EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors
10/20/2004EP1135112B1 An oral formulation for gastrointestinal drug delivery
10/20/2004EP1131291B1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
10/20/2004EP1105156B1 Non-virulent porphyromonas gingivalis mutant
10/20/2004EP1032592A4 Antimicrobial peptides
10/20/2004EP1005351B1 Aqueous metal bicarbonate solutions for the treatment of osteoarthritis
10/20/2004EP0983087B1 Multivalent vaccine composition with mixed carrier
10/20/2004EP0959895B1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
10/20/2004EP0954332B1 Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
10/20/2004EP0866696B1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc
10/20/2004EP0771214B1 Treatment and prevention of helicobacter infection
10/20/2004CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease
10/20/2004CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them
10/20/2004CN1538848A Novel Benzo-fused heterocycles
10/20/2004CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
10/20/2004CN1538836A Substituted amine derivatives and method of use
10/20/2004CN1537864A Fern effective part and compound fern glycoside and its separaton and purification method
10/20/2004CN1537852A Anti coxsackie viruse action of quinolixiding kind alkaloid
10/20/2004CN1537849A Hydroxy stilbene kind compound and its preparation method and application
10/20/2004CN1537627A Capsule for treating hepatopathy
10/20/2004CN1537626A Pill for treating lung disease, and its prepn. method
10/20/2004CN1537619A Traditional Chinese medicine for immunity and strengthening the body resistance
10/20/2004CN1537612A Capsule for treating myocarditis of coxsackie B virus type, and its prepn.method
10/20/2004CN1537607A Traditional Chinese medicine for removing heat from liver to reduce transaminase
10/20/2004CN1537602A Traditional Chinese medicine pill for taking care of heart, brain and kidney
10/20/2004CN1537593A Xiaoer Niuhuang Qingfei, granule contg. bezoar for cleaning-away lung-heat of children and its prepn.method
10/20/2004CN1537591A Yinqin Granule contg. Chinese medicines, and its prepn. method
10/20/2004CN1537586A Sanhuang Qingjie dispersing tablet contg. coptis, phellodendronum and others for cleaning heat and detoxicating, and its prepn. method
10/20/2004CN1537582A Shenqi Gankang granule contg. ginseng and ast4ragalus mongholicus for treating liver disease, and its prepn. method
10/20/2004CN1537581A Guanule contg. 'Jigucao' (Abrus fruticulosus Wall. ex Wight at Arn.) for treating hepatitis, and its prepn. method
10/20/2004CN1537577A Xiaoer Niuhuang Qingfei Fensan Contg. bezoar for cleaning lung of children, and its prepn. method
10/20/2004CN1537560A Medicine for treating monilia vaginitis
10/20/2004CN1537559A Traditional Chinese medicine for treating AIDS
10/20/2004CN1537546A Prepn. method of traditional Chinese medicine compound dripping pills
10/20/2004CN1537543A Traditional Chinese medicine for treating high-fever and diarrhoea of AIDS
10/20/2004CN1537539A Coated roxithromycin micro-capsule, and its prepn. method utilizing fluidized bed
10/20/2004CN1537531A Celecoxib compositions
10/20/2004CN1171996C American pig reproduction and respiratory syndrome syndrome (PRRS) virus and its use
10/20/2004CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
10/20/2004CN1171887C Respiratory syncytial virus replication inhibitors
10/20/2004CN1171874C Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer
10/20/2004CN1171870C Inhibitors of cysteine protease
10/20/2004CN1171637C Vaccine against nepatitis B Birus and human papilloma virus
10/20/2004CN1171631C Gamma & T cell immunoactivity potentiators containing shiitake mushroom hypha extract
10/20/2004CN1171623C Preon of medicine for treating hepatosis
10/20/2004CN1171613C Medcine for external applicationf or curing dermal viral infection and its preparation method
10/20/2004CN1171611C Powder medicine for treating cerebritis
10/20/2004CN1171603C Granule for clearing away heat and dispelling watness-evil
10/20/2004CN1171601C Medicine for treating nephrosis and lung disease
10/20/2004CN1171589C Urease inhibitors
10/19/2004US6806369 N-formyl-n-hydroxy-2-(5-isoquinolinoxy)ethylamine anti-bacterial compounds
10/19/2004US6806277 Quinolylpropylpiperidine derivatives, preparation process and intermediates, and compositions including them
10/19/2004US6806270 Selective antagonists of A2B adenosine receptors
10/19/2004US6806265 For therapy and prophylaxis of hiv infection
10/19/2004US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent
10/19/2004US6806256 Especially a bitter tasting antibiotic containing an artificial sweetener
10/19/2004US6806253 Therapeutic and preventive anti-bacterial vaccine complex
10/19/2004US6806243 Ophthalmic solution and contact lens solution
10/19/2004US6806086 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
10/19/2004US6806063 Protein conjugate for use in the treatment of blood disorder
10/19/2004US6806055 Preparing viral vaccine; obtain glycoprotein, determine neutralizing epitope, generate vaccine associated with neutralizing epitope
10/19/2004US6805863 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
10/19/2004US6805861 Administering therapeutically effective amount of cytotoxic t lymphocytes which have different hla class i complex (or equivalent) than cells to be killed, and specifically recognize peptide portion of antigen presented on cell surface
10/19/2004US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
10/17/2004CA2463827A1 Methods and compositions for controlled release of bioactive compounds
10/14/2004WO2004087925A1 Modified beta-lactamases and uses thereof
10/14/2004WO2004087767A1 Polypeptide
10/14/2004WO2004087759A2 Method and compositions for conversion of antibody activity
10/14/2004WO2004087728A2 6,11-3c-bicyclic 9a-azalide derivatives
10/14/2004WO2004087714A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004WO2004087697A1 N-aryl-2-oxazolidinone-5-carboxamides derivatives with antibacterial activity
10/14/2004WO2004087647A2 4-substituted quinolein derivatives with antimicrobial activity
10/14/2004WO2004087641A1 Hydrazone derivative
10/14/2004WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors
10/14/2004WO2004087189A2 Use of bacteriocin for the amelioration of digestive functionality
10/14/2004WO2004087185A1 Process for preparing antibacterial and antioxidant fraction from seabuckthorn seeds (hippophae rhamnoides l.)
10/14/2004WO2004087169A1 Antiviral combination of nevirapine and a further antiretroviral compound
10/14/2004WO2004087143A1 Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials
10/14/2004WO2004087140A1 Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
10/14/2004WO2004087139A1 Antiviral combination of tipranavir and a further antiretroviral compound
10/14/2004WO2004087133A1 Crystalline n-formyl hydroxylamine compounds
10/14/2004WO2004087128A1 Methyl-β-orcinolcarboxylate from lichen (everniastrum cirrhatum) for use for the treatment of fungal infections and cancer
10/14/2004WO2004087122A1 (+)-1-bisabolone isolated from cymbopogon flexosus and antibacterial activity thereof
10/14/2004WO2004087067A2 Treatment of aspergillus infections with thymosin alpha 1
10/14/2004WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages)
10/14/2004WO2004060379A3 Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications
10/14/2004WO2004052905A3 Antiviral nucleoside derivatives
10/14/2004US20040204673 Modular infusion device and method
10/14/2004US20040204596 preventing or treating degradation of collagen, degradation of collagen by bacterial collagenases during a bacterial infection, regeneration of skin and ligaments, tumoral invasion and degenerative diseases having fibrinoid degeneration of collagen
10/14/2004US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity
10/14/2004US20040204568 Comprises nucleotide sequences coding cell adhesion molecules for use in the diagnosis, prevention and treatment of autoimmune and cell proliferative disorders
10/14/2004US20040204565 Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
10/14/2004US20040204493 Carbonic anhydrase inhibitors as drugs to eradicate Helicobacter pylori in the mammalian, including human, stomach
10/14/2004US20040204481 Activation of natural killer cells by adenosine A3 receptor agonists
10/14/2004US20040204465 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
10/14/2004US20040204463 Aantimicrobials with activity against human and veterinary pathogens: Gram-positive aerobic bacteria multiply-resistant staphylococci and streptococci, anaerobic organisms bacteroides and clostridia and acid-fast organisms such as Mycobacterium
10/14/2004US20040204452 to decompose peroxynitrite anion into harmless nitrate or nitrite endproducts which prevents the free radical-mediated cell damage; cytoprotective; Alzheimer's disease; 3,5-dimethylisoxazole-4-sulfonic acid 4-pyrrolidin-1-ylphenylamide